KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -14.3% | 1,000 | -11.1% | 0.00% | – |
| Q3 2021 | $7,000 | -84.8% | 1,125 | -74.6% | 0.00% | – |
| Q2 2021 | $46,000 | +24.3% | 4,436 | +26.7% | 0.00% | – |
| Q1 2021 | $37,000 | -31.5% | 3,500 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $54,000 | +671.4% | 3,500 | +600.0% | 0.00% | – |
| Q3 2020 | $7,000 | -30.0% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |